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Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited disorder, which is caused by a
pathological expansion of a polyglutamine (polyQ) tract in the coding region of the ATXN2 gene. Like other
ataxias, SCA2 most overtly affects Purkinje cells (PCs) in the cerebellum. Using a transgenic mouse model
expressing a full-length ATXN2Q127-complementary DNA under control of the Pcp2 promoter (a PC-specific
promoter), we examined the time course of behavioral, morphologic, biochemical and physiological changes
with particular attention to PC firing in the cerebellar slice. Although motor performance began to deteriorate
at 8 weeks of age, reductions in PC number were not seen until after 12 weeks. Decreases in the PC firing
frequency first showed at 6 weeks and paralleled deterioration of motor performance with progression of dis-
ease. Transcription changes in several PC-specific genes such as Calb1 and Pcp2 mirrored the time course of
changes in PC physiology with calbindin-28 K changes showing the first small, but significant decreases at 4
weeks. These results emphasize that in this model of SCA2, physiological and behavioral phenotypes precede
morphological changes by several weeks and provide a rationale for future studies examining the effects of
restoration of firing frequency on motor function and prevention of future loss of PCs.
INTRODUCTION
Background
Spinocerebellar ataxia type 2 (SCA2) is one of the six cerebel-
lar neurodegenerative disorders caused by a mutant polygluta-
mine (polyQ) protein. In addition to these cerebellar disorders
(SCA1, 2, 3, 6, 7 and 17), Huntington disease, dentatorubral-
pallidoluysian atrophy and spinal bulbar muscular atrophy
(SBMA) are also polyQ disorders, but affect primarily other
neuronal groups. These disorders all show autosomal domin-
ant inheritance and are caused by expansion of a CAG DNA
repeat in the coding region of the respective gene. In SCA2,
these excessive CAG repeats in exon 1 of the ATXN2 gene
cause expansion of a polyQ domain in the protein ataxin-2
(ATXN2). As in the other polyQ disease, the size of the
polyQ repeat is inversely associated with age of onset (AO)
in SCA2 (1,2). Evidence suggests polyglutamine disorders
exert their pathology through a toxic gain of function of the
protein and larger polyQ expansions have been associated
with greater pathology along with an earlier AO of motor def-
icits, although this is subject to variability (3). ATXN1, is
widely expressed in the brain (4,5); however, neurodegenera-
tion is limited to cerebellar PCs, and neurons in the brainstem
and spinal cord (6). As with most autosomal dominant ataxias,
symptoms are characterized by a progressive loss of motor co-
ordination, neuropathies, slurred speech, cognitive impairment
and loss of other functional abilities arising from deep cerebel-
lar nuclei (7).
ATXN2 is widely expressed in the mammalian nervous
system (1,8,9). It is known to associate with the endoplasmic
reticulum (10), the Golgi complex (11) and has been
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implicated in messenger RNA (mRNA) translation and trans-
port (12). Other data suggest that ATXN2 may be an important
component of energy metabolism and weight regulation. For
example knockout (KO) mouse models of ATXN2 develop
obesity (13,14). ATXN2 orthologs have been suggested to be
involved in long-term habituation at the synapse in fruit flies
(15). Work in the Caenorhabditis elegans model continues
to support ATXN2′s function in translational regulation (16),
as well as embryonic development (13). Furthermore,
ATXN2 is a known to interact with the poly-A binding
protein 1 and assemble with polyribosomes, which implicates
ATXN2 as being involved in the metabolism of RNA (17).
Emerging evidence suggests that ATXN2 may also be
involved in endocytosis and epidermal growth factor receptor
trafficking (18) as well as actin filament formation (19).
The AO of SCA2 symptoms exhibits an inverse correlation
to the number of glutamine repeats. Recent work has reported
that glutamine expansions in the C-terminal domain of the
CACNA1a gene, which codes for the voltage-activated
calcium channel Cav2.1, may interact with ATXN2 and accel-
erate the AO of the disease (2). Despite this relative wealth of
information regarding the normal function of ataxin-2, little is
known about whether the expansion of the polyQ domain
leads to a gain of normal function or gain of a novel toxic
function.
Relatively little is known about the early cellular events
and physiological changes induced by mutant polyQ proteins
in the cerebellum. PCs in the cerebellum receive input from
the two major afferent pathways to the cerebellum, the climb-
ing fiber and mossy/parallel fiber pathways. Climbing fibers
from the inferior olive synapse in a one-to-one fashion onto
PCs, whereas mossy fibers synapse on granule cells which,
in turn, give rise to parallel fiber axons that converge massive-
ly (100 000 to 1) onto PC dendrites (20). PCs exhibit tonic
action potential firing due to intrinsic pacemaking (21); they
are also excited by parallel and climbing fiber input. PCs are
the only output from the cerebellar cortex and they project
to and inhibit deep cerebellar nuclear neurons. Studies of
mutations in specific genes causal in human ataxias have
provided differing results with regard to the PC spiking fre-
quency and the persistence and regularity of their tonic
firing (22–24).
We previously reported on a transgenic mouse model of
SCA2, which targeted the expression of a full-length-mutant
ATXN2Q58 complementary DNA (cDNA) to PCs using the
Purkinje cell protein-2 (Pcp2) promoter (25). This model
showed a late-onset progressive motor phenotype accompanied
by the formation of diffuse cytoplasmic aggregates. Although
actual cell loss of PCs was relatively minor even at 12
months, shrinkage of the molecular layer and reduction of cal-
bindin staining in PCs and dendrites were observed earlier.
By using a longer polyglutamine repeat, we have now gen-
erated an SCA2 mouse model that shows a more clearly
defined phenotype along with an earlier degenerative onset.
Using this model, we investigated early changes in biochem-
ical and cellular functions of PCs. In particular, we sought
to examine the interplay between PC dysfunction in the
slice, changes in gene expression, reduction in the molecular
layer size and in PC number and the resulting effects on
motor behavior.
RESULTS
Ataxin-2-mutant mice exhibit an early pathological motor
phenotype
SCAs commonly show disease onset in early adulthood with
progressive worsening of symptoms with age. In modeling
the human SCA2 phenotype, we therefore sought to recapitu-
late normal motor function in young animals followed by
a progressive deficit with age. Indeed, ATXN2Q127 mice at
4 weeks performed similar to wild-type (WT) littermates
on the accelerating rotarod (Fig. 1). With age, however,
ATXN2Q127-mutant mice demonstrated a progressive decline
in motor performance. Two-way analysis of variance
(ANOVA) determined that ATXN2Q127 mice exhibited a sig-
nificant age-related decrease of motor performance. Signifi-
cant main effects were detected for genotype (F ¼ 54.51,107),
age (F ¼ 15.24,107) and an interaction of genotype × age
(F ¼ 4.14,107). Bonferroni post-hoc tests revealed no signifi-
cant difference between genotypes at 4 weeks of age.
However, statistically significant differences emerged as
early as 8 weeks (P, 0.05), and increased at ages 12 (P,
0.001), 24 (P , 0.0001) and 36 (P, 0.001) weeks. Thus,
motor behavior was normal from birth to 4 weeks, showed
minor, but significant impairment by 8 weeks, which then
progressively worsened over the ensuing 28 weeks.
Mutant ataxin-2 expression results in a loss of molecular
layer volume and aggregate formation in cerebellar
Purkinje cells
Along with the overt motor phenotype, we observed anatom-
ical abnormalities associated with expression of the transgene
in mutant mice, although at latter ages. Figure 2A–J shows
representative images of WT (top row) and ATXN2Q127 cere-
bellar sections (bottom row) across five different age points
(columns). Two-way ANOVA detected a significant main
effect of genotype (F ¼ 47.21, 20). Bonferroni post-hoc tests
determined that mutant animals at 12 (P, 0.05), 24 (P,
0.01) and 40 (P, 0.001) weeks of age exhibited a significant
Figure 1. Progressive deterioration of motor performance on the accelerating
rotarod beginning after 4 weeks of age. Latency to fall off the accelerating
rotarod (left Y-axis) and RPMs (right Y-axis) data for ATXN2Q127 (gray
circle) and WT animals (white circle). Data represent the mean+SEM of
three trials on the test day. Number of animals tested for WT and
ATXN2Q127 animals are listed above and below, respectively. Two-way
ANOVA comparing the age × genotype; Bonferroni post-hoc tests. ∗P ,
0.5, ∗∗P, 0.01, ∗∗∗P , 0.001. Error bars represent +SEM.
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loss of molecular layer thickness (Fig. 2K). Overall cell loss in
ATXN2Q127 animals exhibited a significant main effect of
genotype (F ¼ 7.161, 20). Bonferroni post-hoc tests indicated
that only 40-week-old ATXN2Q127 differed from WT
(Fig. 2L). Despite normal motor behavior at the age of 4
weeks, perinuclear ataxin-2 aggregates were already detect-
able at that time in some PCs with an antibody targeting an
epitope shared by human and mouse ATXN2 (Fig. 3). The
number of PCs showing inclusions and the size of inclusions
increased with age, whereas diffuse cytoplasmic staining
became nearly undetectable at advanced ages.
Deficits in cerebellar gene expression precede motor
phenotype and anatomical degeneration in
ATXN2Q127-mutant animals
To examine changes in gene expression, we focused on genes
known to be specifically expressed in PCs such as Calb1
(encoding calbindin 28K) and Pcp2 (encoding PC protein 2)
and several additional genes the expression of which is
enriched in but not exclusive to PCs (Fig. 4). This experimen-
tal design allows comparison between the WT and transgenic
animal expression within a given time point, but not across
different time points. Additionally, we tested age points at
which no significant loss of PC bodies was detected. At
postnatal day 1, ATXN2Q127and WT animals exhibited
similar gene expression (data not shown). As early as 4
weeks, ATXN2Q127animals exhibited a modest, yet statistically
significant reduction in the expression of Calb1 (P , 0.05),
whereas all other genes tested remained unchanged from
WT (Fig. 4A). At 8 weeks of age, quantitative polymerase
chain reaction (qPCR) analysis ofATXN2Q127mice confirmed
the trend of decreased Calb1 expression (P , 0.001) as well
as a significant reduction in Pcp2 (P , 0.01), Grid2 (P ,
0.001) and Grm1 (P, 0.05) expression (Fig. 4B).The gene
expression changes continued at 12 weeks of age (Fig. 4C).
By 24 weeks, a reduced expression in Itpr1 (P, 0.05) was
detected for the first time (Fig. 4D). The qPCR data displayed
here also indicate that across all ages mouse ataxin-2 (mAtxn2)
remained unchanged throughout the study and in fact mutant
mice displayed a modest, but non-significant, increase in
mAtxn2 expression. The human ATXN2-mutant transgene is
also present in ATXN2Q127 animals, as would be expected,
and although variability existed between ages, expression
remained similar across all ages of mice tested. In summary,
qPCR data demonstrated that PC-specific genes showed a dif-
ferential reduction in expression, which was progressive with
time. However, even among the few genes tested by qPCR, the
reduction in expression was not global. Cacna1a did not
change significantly and Itpr1 only at 24 weeks. On the
Figure 2. Changes in PC number and molecular layer thickness occur late in ATXN2Q127 mice. Representative confocal images stained for calbindin 28-k from
the ‘fissura prima’ of the cerebellar vermis: WT animals (A–E) and ATXN2Q127 transgenic mice (F–J) at 4, 8, 12 and 24 weeks of age are shown. (K) Graphical
representation of changes in the molecular layer thickness. (L) PC count of ATXN2Q127 (gray bars) and WT (white bars) animals across age. N ¼ 2–3 animals for
each category. Two-way ANOVA comparing the age × genotype; Bonferroni post-hoc tests. ∗P , 0.05; ∗∗P , 0.01; ∗∗∗P , 0.001. Error bars represent +SEM.
Scale bar ¼ 200 mM
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other hand, reduction of Calb1 preceded loss of molecular
layer thickness by several weeks.
Electrophysiological behavior of Purkinje cells in mutant
mice
We decided to investigate whether physiological functional
changes in PCs correlated with the ataxic phenotype of our
ATXN2Q127mouse model seen in the accelerated rotorod be-
havior (see Fig. 1). We exploited the fact that normal
healthy PCs exhibit intrinsically generated, regular firing
(21,26), and used a noninvasive extracellular recording tech-
nique to study PC firing in cerebellar slices at different ages
(4–40 weeks) in WT and ATXN2Q127 mice at a near physio-
logical temperature of 34.5+ 18C.
Representative traces of both WT and ATXN2Q127 mice
from each age group investigated are presented in Figure 5.
Each panel shows recording data from one second in time
and includes as an inset a histogram of all interspike intervals
(ISI) in a 2 min recording period from that PC. The mean
firing frequency and the coefficient of variation of the ISI
are indicated in each inset. These data from individual PCs
highlight a marked slowing in the firing rate with age in the
ATXN2Q127mice.
In WT animals, each PC fires at a characteristic rate (21).
To document the average firing behavior of the population
of PCs, the mean firing frequency was calculated over 2 min
epochs for each PC and population distributions of these
mean values are plotted in Figure 6 for each age group and
genotype. The mean firing frequencies from 6 to 40 weeks
are unchanged in the WT, whereas in the ATXN2Q127 mice
over the same age range the distributions progressively shift
to slower firing frequency.
Figure 7 summarizes the average firing frequency, regularity
of firing and fraction of cells firing regularly as a function of
age and genotype. In WT PCs, we saw an initial increase in
Figure 3. Ataxin-2 aggregates detected in mutant mice. As early as 4 weeks, occasional PCs show perinuclear aggregates. Note that at 24 weeks only aggregates
remain visible. Representative immunohistochemical images from combined double staining for WT (A–D) and ATXN2Q127 (E–H) mice. Antibodies directed
against calbindin 28-k (red) and ataxin-2 (green) detected the presence of aggregate formations (white arrows) in ATXN2Q127 animals across all age points. All
images for a respective antibody were taken at the same exposure times. Scale bar ¼ 100 mM
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the mean firing frequency during maturation from 30+1 Hz
(n¼ 120) at 4 to 42+1 Hz (n ¼ 72) at 6 weeks, after which
it remained essentially constant (45 Hz) from 6 to 40 weeks
of age. In contrast, the firing rate of PCs measured in
ATXN2Q127 mice progressively declined (from 35 at 6– 11 Hz
at 40 weeks) (Fig. 7A). Two-way ANOVA revealed the main
effects of genotype (F ¼ 246.61,976), age (F ¼ 10.85,976) and
genotype × age (F ¼ 42.75,976). The Bonferroni post-hoc test
showed that WT and ATXNQ127 groups were not significantly
different at 4 weeks, first became statistically different at 6
weeks (P ¼ 0.015) and remained significantly different at 8
(P ¼ 0.000024), 12, 24 and 40 weeks (all P, 8 × 1027).
The majority of PCs fired regularly and we observed only a
very small fraction of bursting cells which showed no differ-
ences between the WT and transgenic groups (Fig. 7B). We
quantified the regularity of firing by calculating the coefficient
of variation of adjacent spikes (27), an index for which higher
values indicate less regular firing. In WT PCs, there is a small
increase in firing variability from 12 to 40 weeks. Despite the
marked decrease in firing frequency, the firing regularity
remained remarkably constant in ATXN2Q127mice and no stat-
istically significant differences were observed for age or geno-
type (two-way ANOVA, Fig. 7C).
Rbfox1-mediated splicing is not altered in mutant mice
ATXN2 is known to interact with Rbfox1 (28) and PC-specific
deletion of Rbfox1 and Rbfox 2 results in splicing
abnormalities in several genes, including ion channel-forming
genes in PCs (29). Here, we sought to examine whether the
mutant transgene resulted in changes in the relative abundance
of splice variants in channel-forming genes which may
account for the reduction in endogenous PC firing frequency.
We performed RT-PCR on samples from both young (4
weeks) and older (24 weeks) WT and mutant mice (Fig. 8).
No alternative splice differences were detected between
ATXN2Q127 mice and WT litter mate samples in any of the
three Ca2+ channels: Cacna1B, Cacna1D and Cacna1S
(Fig. 8). Interestingly, Cacna1S failed to amplify any
product for 4-week-old mice. Cacna1B primers were designed
to amplify two bands corresponding to 235 and 172 bp. In this
case, a ratio was taken from the intensity signal of the upper
and lower bands (Table 1). The ratios were log transformed
and averaged followed by a two-tailed paired t-test. No differ-
ence was statistically observed between genotypes (P . 0.05).
Two genes encoding for K+ channels, Kcnd3 and Kcnq2, also
failed to indicate differences in splice variants between
ATXN2Q127 and WT samples. Like the aforementioned
Cacna1B, both the K+ channel primer sets also amplified
two endogenous bands. Kcnd3 primers amplified two bands
at 233 and 166 bp respectively. In 24-week-old animals, the
larger band appeared to be preferentially amplified regardless
of the genotype. No such distinction between the upper and
lower bands was present in 4-week-old samples. Kcnq2 also
amplified two bands of 227 and 197 bp in length. In both 4-
and 24-week-old animals, there appeared a preferential
Figure 4. Early expression changes of key cerebellar genes including several PC-specific genes at four time points. Significant reductions in four genes are seen
at 8 weeks, but not 4 weeks except for a minor reduction in calbindin mRNA levels. Quantitative PCR data from mouse cerebella comparing PC-specific gene
expression of ATXN2Q127 (gray bars) and WT animals (white bars) (A–D). Genes tested: human transgene (h ATXN2), mouse ataxin-2 (mAtxn2), PC protein 2
(Pcp2), calbindin 28-k (Calb1), metabotropic glutamate receptor 1 (Grm1), glutamate receptor ionotropic delta-2 (Grid2), calcineurin (Ppp3ca), glutamate
decarboxylase (Gad1), voltage-gated calcium channel Cav2.1 (Cacna1a), inositol triphosphate receptor 1 (Itpr1). N, size for each genotype and age group is
listed in brackets. Gene expression normalized to the Wasf1 housekeeping gene. Student’s two-tailed t-test compared ATXN2Q127 with WT gene expression
in each age group. ∗P, 0.05, ∗∗P , 0.01, ∗∗∗P , 0.001. Error bars represent +SEM.
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amplification of the larger band. As with the previous
Cacna1B assay, a t-test on log-transformed Kcnq2 data
failed to detect a statistically significant difference in band in-
tensity when comparing across genotypes (P. 0.05). Finally,
we looked for mutually exclusive splice variants in the Scn8a
gene encoding for transmembrane portions of the sodium
channel Nav1.6. Here, we looked both at Scn8a (5) with
primers targeted to exon 5, which is responsible for encoding
the S3–S4 segment of domain I. We observed only the pres-
ence of the upper band in both genotypes at both ages.
Figure 5. PC firing rate remains constant in WT but progressively decreases with age in ATXN2Q127 mice. To the left of each panel are examples of extracellular
recordings from PCs at the indicated ages in WT and transgenic ATXN2Q127 mice. These one second traces show that firing decreases progressively with age in
the transgenic (ATXN2Q127) but not WT mice. To the right of each panel are histograms of inter spike intervals for the 2 min recording periods from the same
neuron. Indicated on each histogram are the mean firing rate and the local coefficient of variation (CV). All recordings were made at 34.5+18C and the ex-
perimenter was blinded to the genotype.
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Additionally, we looked at Scn8a (18) on exon 18, which
encodes for the S3–S4 segment of domain III of the mem-
brane spanning protein. Here, again we observed only the
presence of the larger band.
DISCUSSION
We present evidence of early endophenotypic markers asso-
ciated with pathological expansion of the polyglutamine
tract in ATXN2 in a new mouse model of SCA2. By collecting
biochemical, electrophysiological and behavioral data across a
wide range of ages, from presymptomatic to late stages, we
have obtained a comprehensive picture of disease progression.
The first observable changes occurred at 4 weeks and were
biochemical, and these were followed by changes in the elec-
trophysiological behavior of PCs which were statistically sig-
nificant at 6 weeks. Finally, deficits in motor behavior became
significant at 8 weeks. Biochemical, electrophysiological and
behavioral deficits worsened over the period between 8 and
40 weeks but PC cell loss was not apparent until 40 weeks.
Figure 6. Population distributions of the mean PC firing rate show a shift towards slower firing with age in SCA2Q127 mice. Each histogram displays the dis-
tribution of mean firing rates of WT (black traces) and ATXN2Q127 PCs (gray filled traces) with the y-axis indicating the percent of total PCs recorded. The
numbers of recorded PCs are 4 weeks: 120 WT, 79 ATXN2Q127; 6 weeks: 73 WT, 75 ATXN2Q127; 8 weeks: 48 WT, 54 ATXN2Q127; 12 weeks: 84 WT, 100
ATXN2Q127; 24 weeks: 59 WT, 85 ATXN2Q127; 40 weeks: 98 WT, 82 ATXN2Q127.
Figure 7. Mean firing rate in PCs decreases but firing variability and fraction of regularly firing cells are unchanged in ATXN2Q127 mice. (A) The mean frequency
values in Hertz, shown in black line white circle for WT at 4, 6, 8, 12, 24 and 40 weeks, are 30+1 (n ¼ 120), 42+1 (n ¼ 73), 46+3 (n ¼ 48), 43+2 (n ¼
84), 43+2 (n ¼ 59) and 48+3 (n ¼ 98), respectively. Significantly reduced PC firing frequency is already evident in ATXN2Q127 mice as early as 8 weeks of
age and subsequently worsens. The mean values in Hertz for ATXN2Q127 PCs shown in gray are 34+0.9 (n ¼ 79), 35+1 (n ¼ 75), 32+3 (54), 27+1 (n ¼
100), 17+1 (n ¼ 85) and 11+1 (n ¼ 82) at 4, 6, 8, 12, 24 and 40 weeks, respectively. (B) The fraction of cells that show bursting behavior is low and does not
differ significantly between the WT and ATXN2Q127 groups. (C) The coefficient of variation of adjacent intervals, a measure of the regularity of firing, is not
significantly changed between WT and ATXN2Q127 mice. The firing variability values for control mice at different age groups are 0.068+0.0003, 0.114+0.009,
0.098+0.009, 0.085+0.005, 0.146+0.017 and 0.132+0.01 at 4, 6, 8, 12, 24 and 40 weeks, respectively, versus 0.057+0.005, 0.091+0.023, 0.077+
0.008, 0.083+0.006, 0.109+0.016 and 0.1+0.01 in SCA2 transgenic mice at the same age group, respectively. Data in (A) and (C) are expressed in
mean+SEM. Two-way ANOVA comparing age × genotype followed by Bonferroni post-hoc tests yielded P-values indicating significant differences
between WT and ATXN2Q127 mice: ∗P ¼ 0.015, ∗∗P ¼ 0.00024 and ∗∗∗P, 8 × 1027.
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Taken together, these data suggest a sequence of events in
which concerted biochemical dysregulation leads to impair-
ment of the basic electrophysiological function of PCs and
this contributes to ataxic symptoms.
In this study, we characterized the effects of a transgene
expressing a full-length cDNA construct with a long uninter-
rupted CAG repeat. In a prior study, we had examined the
effects of a full-length transgene with 58 CAG repeats,
again using the Pcp2 promoter (25). Consistent with studies
in SCA2 patients, AO was much earlier in the ATXN2Q127
line than in the ATXN2Q58 line (1,2). During the study of
the ATXN2Q58 mouse model, we also had generated two
lines expressing a human ATXN2 cDNA encoding Q22, the
most common normal allele in human populations. These
ATXN2Q22 lines expressed the transgene at similar levels as
the ATXN2Q58 lines, but did not show motor or anatomical
phenotypes at 12 months of age and were subsequently termi-
nated. Despite the absence of changes in cerebellar morph-
ology or rotarod performance, we cannot exclude that
studies at the transcriptome or single cell level would have
revealed subtle changes or that changes would have occurred
at 18 or 24 months of age.
At the biochemical level, we observed progressive declines
in a number of PC-enriched gene products which in some
cases preceded cell loss. For example, mRNA levels of the
intracellular calcium-regulating gene, Calb1, were normal at
birth, significantly downregulated as early as 4 weeks of
age, and exhibited a continual decline of expression at ages
Figure 8. RT-PCR for Rbfox1-mediated alternative splice variants. RT-PCR gel images of alternative splice sights in channel-forming genes. Two age points (4
weeks: left column; 24 weeks: right column) were tested. WT ¼ wild type, Tg ¼ Atxn2Q127. Voltage-dependent calcium channels: Cav2.2 (Cacna1B), Cav1.3
(Cacna1D), Cav1.1 (Cacna1s). Voltage-gated potassium channels: Kv4.3 (Kcnd3), Kv7.2 (Kcnq2). Voltage-gated sodium channel Nav1.6: exon 5 (Scn8a (5)),
exon 18 (Scn8a (18)).
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older than 4 weeks. A reduced expression of Calb1 was fol-
lowed by a significant reduction in Pcp2, Grm1 and Grid2 ex-
pression at 8 weeks, each of which also demonstrated a
progressive diminished expression with age. The reduced ex-
pression of these genes was not a function of PC death, as
number of PCs between WT and ATXN2Q127 remained rela-
tively constant until 40 weeks of age.
Consistent with our findings, mouse strains in which these
genes are deleted show ataxic phenotypes. Calbindin 28-K
null mice exhibit normal nervous system development and
cerebellar histology, but these mice go on to develop impair-
ments in motor performance linked with alterations in synaptic
calcium currents (30). Calbindin and parvalbumin reductions
have also been described in SCA1-mutant mice and the loss
of calcium buffering capacity has been suggested to contribute
to pathology (31). However, there is a debate as to whether
elevated calcium is a primary contributor to subsequent PC
loss and ataxic behavior (32).
Abnormalities in handling of calcium fluxes have been
implicated in neurodegeneration in general (for reviews, see
33 and 34) and within the family of trinucleotide repeat disor-
ders (35–39). In human ataxia patients, a normal variation in
the polyQ repeat in Cacna1a (Cav2.1) modifies the AO in
SCA2 patients (2). Cacna1a expression, however, was not
altered in our SCA2 mouse model until very late in the
disease, and even then reduction did not reach significance
and may have been solely due to loss of PCs at that stage.
Mutant ATXN2 protein physically interacts with the IP3 re-
ceptor (IP3R1) and leads to enhanced calcium release from
intracellular stores upon mGluR1 stimulation (36). Dysregula-
tion or mutation of IP3R1 may also be important in other
SCAs (40). Slight decreases in the expression of Grm1, the
gene encoding mGluR1, were seen beginning at 8 weeks in
transgenic animals, whereas changes in Itpr1 expression
occurred later and only reached significance at 24 weeks.
The downregulation of Grid2 and Grm1 early in the disease
process may in itself hasten dysfunction and degeneration in
vivo. Mutant mGluR1 KO mice display cerebellar ataxia
along with impaired motor learning and loss of long-term
depression (41). Abnormal calcium handling in the early
stages of SCA2 pathogenesis may be further aggravated by
reduction in Calb1 expression and calbindin-28K protein
levels. In our model, reduction of Calb1 as measured by
qPCR preceded the onset of physiologic abnormalities by
2 weeks and of behavioral abnormalities by 4 weeks and
worsened with disease progression.
Grid2 is localized to the PC-parallel fiber synapse and
is reported to be involved in the maintenance of synapse
integrity, as well as long-term depression. Importantly,
Grid2 is also involved in cerebellar motor coordination and
learning (for review, see 42). Alterations in Grid2 expression
have also been linked to ataxic phenotypes and loss of
PCs. Mutations in the N-terminal domain of Grid2, the
hotfoot allele, lead to ataxia of the hindlimbs in mice (43).
Lurcher mice express a lethal point mutation in the Grid2
gene, resulting in excitotoxic apoptosis of PCs (44, reviewed
in 45).
Using a noninvasive recording technique, we measured PC
firing in WT and ATXN2Q127 mice from 4 weeks until
40 weeks of age. In WT mice, at 4 weeks of age, the mean
PC firing frequency was 30 Hz (n ¼ 120) and climbed to
45 Hz at 6weeks and remained essentially unaltered across
the age range studied. By comparison, in ATXN2Q127 mice,
the mean PC firing frequency was identical to WT at
4 weeks but began to decline and was significantly lower
at 6 weeks. The firing rate declined progressively, such that
at 40 weeks PCs fired on average at 25% the WT rate.
These physiological data correlate with the rotarod behavior
which shows no evidence of impairment at early ages but pro-
gressively worsens over a similar age range.
Despite this striking reduction in firing frequency, PCs
maintained highly regular firing patterns as indicated by the
low fraction of cells that exhibited bursting and the low coef-
ficient of variations (CVs). The lack of impairment in regular-
ity is in contrast to reports on mouse models of episodic ataxia
type 2 (EA-2), in which PC firing becomes more variable and
normalization of this variability reduces ataxic behavioral
symptoms (24). The maintained precision in firing will
provide clues as to the types of ion channels which might be
impacted by the pathological process.
Our findings are in rough agreement with a recent study on
a mouse model of SCA1 engineered to express an 82 CAG
repeat expansion under the control of the Pcp2 promoter.
The PC firing frequency in these mice is reduced at
5 weeks, an age at which rotarod performance and eyeblink
conditioning are impaired but there is no sign of altered cere-
bellar morphology or PC loss (22). These findings were linked
to larger A-type potassium currents and reduced glutamate
receptor-mediated synaptic input.
The PC firing frequency was also reduced in a triplet repeat
model of SCA3 (23), but this reduction likely occurs by a dif-
ferent pathophysiological mechanism. In this model, PCs are
silenced as a result of excessive depolarization and consequent
block of electrogenesis. The authors suggest that this silencing
results from alterations in the kinetics of voltage-gated potas-
sium channels (23).
Studies of other models of ataxia have reported more
subtle changes in PC electrophysiology. Point mutations
in the Kv1.1 channel lead to episodic ataxia type 1 (46),
while mutations and triplet repeat expansions in P/Q- type
voltage-gated calcium channels result in EA-2 (24) and in
SCA6 (47), respectively. As mentioned above, reductions
in voltage-gated calcium influx are found in a mouse
Table 1. RT-PCR splice variant ratios. Band intensity values for both 4- and
24-week-old WT (N ¼ 3) and Tg (N ¼ 3) animals. Data represent the ratio of
the upper band to the lower band mean of sample repeated in triplicate. A
paired two-tailed T-test on log-transformed data did not detect any significant
differences between genotypes for any gene at either age (P. 0.05). Voltage-
gated calcium channel Cav2.2 (Cacna1B), voltage-gated potassium channel
Kv4.3 (Kcnd3), voltage-gated potassium channel Kv7.2 (Kcnq2).
Cacna1B Kcnd3 Kcnq2
4 week 24 week 4 week 24 week 4 week 24 week
WT 0.885 0.930 0.970 1.168 1.168 1.438
WT 0.873 0.912 0.990 1.200 1.223 1.594
WT 0.861 0.923 0.972 1.203 1.091 2.011
Tg 0.871 0.930 0.918 1.189 1.247 1.686
Tg 0.837 0.917 0.981 1.179 1.118 1.509
Tg 0.824 0.999 0.936 1.117 1.287 1.774
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model of EA-2 and these reductions lead to less regular PC
pacemaking. A positive modulator of calcium-activated po-
tassium channels restores regular firing and ameliorates
ataxic symptoms in these models, indicating that the
pattern as well as the rate of PC firing likely impact
motor coordination.
Finally, a recent study described a profound impairment in
motor behavior and degradation in both the rate and regularity
of PC firing in a mouse in which the RNA splicing factors
RbFox1 and 2 had been deleted selectively from PCs (48).
Intriguingly, RbFox1 was initially identified and named
ataxin2-binding protein1 based on a yeast 2 hybrid screen
using ataxin2 protein as bait (28). The PC-specific double-
mutant animals showed dysregulation of RNA splicing for
a number of ion channel transcripts known to be implicated
in PC pacemaking. The data discussed in this report,
however, suggest that mutant ATXN2Q127 is not exerting its
toxic effect on PC pacemaking via association with Rbfox1.
Interestingly, in the mouse model presented here, we
observe slowed pacemaking, yet with little variation between
the WT and mutant mice across age. In the Rbfox 1 and 2,
KO mouse model variation of the firing frequency was signifi-
cantly higher than WT animals. Along with our RT-PCR
splice variant data, this provides yet another piece of evidence
that our animal model of SCA2 is working by way of a
mechanism independent of downstream ion channel splice
variants.
These studies highlight a range of proposed pathogenic
mechanisms of expanded repeat alleles of ATXN2. Our physio-
logical results are consistent with broad mechanisms of
mRNA dysregulation, particularly if they result in changes
to ion channel proteins involved in pacemaking. It is also
possible that ATXN2Q127 interacts with specific ion channel
proteins required for pacemaking, explaining the reduction
in this canonical physiological behavior of PCs.
Although loss of specific functions in neurodegenerative
diseases is often attributed to loss of neurons, there is evidence
that some manifestations of these diseases reflect alterations
in neuronal function rather than morphological changes
such as neuronal atrophy and loss. For Huntington disease,
another polyglutamine disorder, early disease stages may
result more from dysfunction than cell death as shown by
recent electrophysiological studies in YAC mice (49). For
polyQ ataxias, this has been supported in an animal model
of SCA1, where behavioral and physiological changes
clearly preceded PC loss and reduction in dendritic volume
(22). In humans, mutations in KCNC3 (Kv3.3) which are
predicted to alter PC firing can lead to progressive cerebellar
degeneration (50,51). Our studies using an SCA2 mouse
model support this notion and show that the earliest changes
in motor behavior are paralleled by changes in gene expression
and PC firing, whereas reductions in molecular layer thickness
and PC number follow much later.
MATERIALS AND METHODS
Animals
Transgenic mouse lines were generated using the pGEM
construct containing the complete human ataxin-2 cDNA
encoding 127 glutamine repeats (Q127) under the control of
the Pcp2 promoter. Constructs were injected into oocytes of
B6D2F1 mice; positive founders were backcrossed to WT
animals of the same hybrid strain, which were used in all
experiments. Mice were housed in a 12/12 h light on–off con-
trolled room: lights on at 0600, with a constant temperature
maintained at 208C. Animals were housed (4 to 5 per cage)
in clear Plexiglas hanging cages (30 × 18 × 15 cm) with
HEPA-filtered air forced through barrier protective lids. All
animals had ad libitum access to food (Lab Diet 5001)
throughout the course of the study, except when being tested
on the accelerating rotarod (90 min per day). WT and trans-
genic (ATXN2Q127) mice were age and weight matched for
each experiment. Only trained personal handled the mice
and all procedures carried out were in accordance with
federal guidelines as well as University of Utah and UCLA
IACUC approved protocols.
Behavioral analysis
Accelerating rotarod: cohorts were age and weight matched
prior to all behavioral experiments. Male and female mice per-
formed equally well; therefore, data were pooled and gender
differences were not evaluated further. One day prior to
testing, mice were placed on the rod rotating at a modest 10
revolutions per minute (rpm) for 2 min in order to acclimate
the animals to the apparatus. Training was conducted over
the course of 2 days. The third consecutive day of accelerating
rotarod exposure served as the test day. Testing data consisted
of the average of three trials. All mice were naive to the task at
the beginning of testing. On the first day of training, animals
were placed on the rod moving at 4 rpm. Over the course of
600 s, the rotational speed smoothly accelerated to 40 rpm
and the latency to fall was recorded for each animal. Once
the animal fell from the apparatus it was immediately returned
to its home cage. A resting period lasting between 20 and
30 min was permitted between trials in order to allow for pos-
sible fatigue recovery.
Immunohistochemistry
Mice were deeply anesthetized with isoflurane, then transcar-
dially perfused with ice-cold phosphate buffered saline (PBS).
Tissue was quickly removed and immediately submerged into
cold 4% paraformaldehyde (Electron Microscopy Sciences)
and kept at 48C overnight. The following day, PFA was
replaced with 10 mM sodium citrate pH 6.0, and again incu-
bated at 48C overnight, after which the tissue was exposed
to microwave radiation three times in10 s bursts. Following
microwave radiation, tissues were cryoprotected by first incu-
bating in 20% sucrose in PBS overnight followed by 30%
sucrose overnight both at 48C. After cryoprotection, the
samples were suspended at optimal cutting temperature
(Sakura Finetek) and kept at 2808C until the time of section-
ing. Tissue sections were cut into 20 mM thick slices and
floated into cold PBS. Tissues were washed three times for
15 min each wash at room temperature (RT) in PBS. A block-
ing/permeabilization solution consisting of 5% skim milk and
0.3% Triton in PBS was left on for 4 h at RT. Following
removal of blocking solution, primary antibodies in wash
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solution were incubated with the tissue slices. Primary anti-
bodies used were as follows: Custom-designed ATXN2 rabbit
polyclonal antibody targeted against the EKSTESSSGPKREE
epitope sequence common to both humans and mice
(SCA2-280), monoclonal mouse anti-calbindin-28k (Sigma).
After 18 h incubation at 48C, excess primary antibodies were
removed using wash solution three times at 15 min each.
DyLight-488 (green) and DyLight-550 (Red) (Thermo Fischer
Scientific) fluorescent secondary antibodies were then incu-
bated with the tissue for 2 h at RT. A final three washes, each
15 min in duration, were used to remove the residual secondary
antibody and finally followed by a 5 min wash using 4’,6-diami-
dino-2-phenylindole (408 nm, blue). Tissue was transferred to
Superfrost Plus microscope slides (Fischer Scientific) and
fixed in place with Prolong Gold (Invitrogen). Quantitative
data were taken from three slices of each of two to three
animals per genotype per age point.
Cell counting on calbindin 28K-stained sections was per-
formed by three independent persons blinded to both the age
and genotype. Counting was performed with images made
from the ‘Fissura Prima’ between lobes V and VI along the
mid-sagittal plane. PC counts were averaged between raters
for three separate animals per genotype per age. The molecular
layer thickness was determined using Nikon EZ-C1 confocal
microscope software. Measurements were taken from the
primary fissure comprised of lobes V and VI, measuring
from the apex of the PC layer to the distal edge of the den-
drites; N ¼ three samples from each age and genotype.
Quantitative PCR
Mice were deeply anesthetized with isoflurane, and cerebella
were removed and immediately submerged in liquid nitrogen.
Tissues were kept at 2808C until the time of processing.
RNA was extracted using the Ambion RNA extraction kit
(Invitrogen) and cDNA synthesized using the QuantiTect
Reverse Transcription kit (Qiagen). Diluted in RNA storage
solution buffer (Invitrogen), cDNA samples were amplified
with the Power SYBR Green PCR Master Mix chemistry
(Applied Biosystems) and run on a Bio-Rad CFX96 qPCR
machine (Bio-Rad). Primers were designed to amplify across
exon/exon boundaries in order to minimize the amplification
of potential contaminating genomic DNA. Each sample was
repeated in quadruplicate and averaged for statistical compar-
isons. Within the quadruplicate repeats, false data were
removed in accordance with the guidelines set forth using
the Dixons Q-test of Outliers. All gene expression values
were normalized to the pan-neuronal housekeeping gene
Wasf1. Primer pairs designed for qPCR are given as forward
and reverse, respectively:
Wasf1: (CCACCCTGCCTGTAATCAGT; GTTTTCAAT
CCGCTCGTGTT);
hATXN2: (AAGATATGGACTCCAGTTATGCAAA; CAAA
GCCTCAAGTTCCTCAT);
mAtxn2: (AAGATACAGACTCCAGTTATGCACGG; GCT
CCAGGTCCTTCTCCTTGTGC);
Pcp2: (ACAGTTAATTCCCTGCCTGG; CTCAAGGAGCTT
GTGTCTGG);
Calb1: (GATTGGAGCTATCACCGGAA; TTCCTCGCAGG
ACTTCAGTT);
Grm1: (TTCCTCAACATTTTCCGGAGAA; ACATGTGCC
GACGGACACT);
Grid2: (GTTGGTCTCGACCTGGGAC; CTGTGCGGAATA
CTTCATCATCT);
Ppp3ca: (CGTTCCATTTCCACCAAGTCAC; GCCTGCCC
TCCTTCATGAGAT);
Gad1: (GGCATCTTCCACTCCTTC; GACGACTCTTCTCT
TCCAG);
Cacna1a: (CCACCCTGCCTGTAATCAGT; GGAAGAATC
TCGGGTGAGGTAC);
Itpr1: (GATGCTAAAGAGGGACAGAAGG; GCAGCGGA
GAATGAGATCAAC).
Electrophysiology
Parasagittal cerebellar slices were made as described earlier
(52). In brief, age-matched WT and ATXN2Q127 mice were
anesthetized using isoflurane and decapitated in accordance
with the protocol approved by the University of California
Los Angeles Institutional Animal Care and Use Committee.
The cerebellum was quickly dissected and placed in ice-cold
extracellular solution (with composition in mM: 119 NaCl,
26 NaHCO3, 11 glucose, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2 and
1 NaH2PO4, pH 7.4 when gassed with 5% CO2 and 95%
O2). Parasagittal cerebellar slices (285–300 mm thickness)
were made using a vibratome (Leica VT1000). The slices
were incubated at 358C for 30 min and stored at RT until
use. Extracellular recordings were made from cerebellar
slices placed in a heated recording chamber where the tem-
perature is maintained at 34.5+ 18C using a dual channel
heater controller (Model TC-344B, Warner Instruments) and
constantly perfused with carbogen-bubbled extracellular solu-
tion at a rate of 2.8–3 ml per min. PCs were visualized using
infrared differential interference contrast optics with an
upright microscope (Leica) using ×40 water immersion ob-
jective. Recordings were made with borosilicate glass pipettes
with resistances between 1 and 3 MV when filled with extra-
cellular solution. To record action potential-associated capaci-
tative current transients, the pipette potential was held at 0 mV
and placed close to the axon hillock (soma/axon) of a Purkinje
neuron. Recordings were made using Axon amplifiers 200B or
700B (Axon Instruments) in voltage-clamp mode. Currents
were filtered at 2 kHz and sampled at 10 kHz using a Digidata
1440 (Axon Instruments). Spike detection and analysis were
either carried out in pClamp 10 or with routines written in
Igor (TaroTools, Dr Taro Ishikawa, https://sites.google.com/
site/tarotoolsregister) and further analysis was performed
using Excel or Igor software. Figures were made in Igor.
The results are reported as mean+SEM. Two minute dur-
ation extracellular recordings were collected from 50–120
PCs from two to seven mice for each genotype and age, and
the experimenter was blinded to the genotype.
RT-PCR
RNA was isolated from mouse cerebellar tissue and trans-
formed to cDNA as previously described (see above). Young
4 week and older 24 week samples from both WT (N ¼ 3,
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N ¼ 3) and ATXN2Q127 (N ¼ 3, N ¼ 3) mice were examined
with primers designed to detect splice variant formations
defined as 300 bp upstream and downstream from the
(U)GCAUG alternative exon motif (48). Using HotStar Taq
Plus (Qiagen), thermocycler conditions employed an anneal-
ing temperature of 608C repeated for 30 cycles. The resultant
product was visualized with ethidium bromide on a 2% agrose
gel. Primers for Cacna1B, Kcnd3 and Kcnq2 amplified two en-
dogenous bands. In these cases, samples were repeated in trip-
licate and analyzed for intra-sample band intensity using
Kodak Molecular Imaging Software (v 5.0.1.27). The values
were obtained by taking a ratio of the upper band to the
lower band. The resultant ratios were log transformed and
averaged for statistical comparisons between WT and
ATXN2Q127 mice. The primer sequence is given as forward
and reverse, respectively:
Cacna1B: (GATGGAAGAAGCAGCCAATC; ACGCAGAT
TCTGGAGCCTTA);
Cacna1D: (CCCAATGGAGGCATCACT; CTTCCAGCTGC
TGTTTTTCC);
Cacna1S: (TTTGGAGATCCTTGGAATGTG; AGTCTCAT
GACCCGGAACAG);
Kcnd3: (GGCAAGACCACCTCACTCA; ACTGGCTGGAC
AGAGAAGGA);
Kcnq2: (CCCTGAAAGTCCAAGAGCAG; CTCCAGCTGG
TTCAGAGGTG);
Scn8a (5): (GACCCGTGGAACTGGTTAGA; TCCAGATAG
CTCTCGTTGAAGTT);
Scn8a (18): (AAATGGACAGCCTATGGCTTC; TCACCTC
GTCGATTTCGAACCG).
Statistics
Two-factor ANOVA followed by Bonferonni post-hoc tests
corrected for multiple comparisons at each age was used to
compare between genotypes and across age for rotarod, cere-
bellar morphology and PC firing analysis. For qPCR and
RT-PCR analysis, Student’s two-tailed t-test was performed
on data comparing ATXN2Q127 and WT gene expression
within each age group.
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